Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Fischer Medical Ventures's Pretax Margin % or its related term are showing as below:
BOM:524743'
s Pretax Margin % Range Over the Past 10 Years
Min: -22.29 Med: 0.65 Max: 15.02
Current: 15.02
BOM:524743's Pretax Margin % is ranked better than 78.21% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.61
vs BOM:524743: 15.02
Fischer Medical Ventures (BOM:524743) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Fischer Medical Ventures Pretax Margin % Related Terms
Fischer Medical Ventures Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:524743 vs ABT, SYK, MDT: Pretax Margin % Comparison
For the Medical Devices subindustry, Fischer Medical Ventures's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fischer Medical Ventures Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fischer Medical Ventures's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Fischer Medical Ventures's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fischer Medical Ventures (BOM:524743) has a Pretax Margin % of -2.32% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Fischer Medical Ventures and its competitors. According to the industry distribution chart, Fischer Medical Ventures ranks #178 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 21.8%.
Is Fischer Medical Ventures' Pretax Margin % too high?
Fischer Medical Ventures' current Pretax Margin % is -2.32%. Based on the distribution chart, Fischer Medical Ventures ranks #178 out of 817 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Fischer Medical Ventures has a GF Score™ of 40/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Fischer Medical Ventures' Pretax Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Fischer Medical Ventures ranks #178 out of 817 companies for Pretax Margin %. This places Fischer Medical Ventures in the top 22% of its industry — outperforming the majority of peers. The industry median Pretax Margin % is 2.61. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.61, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Fischer Medical Ventures and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fischer Medical Ventures's current Pretax Margin % is -2.32%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fischer Medical Ventures stock overvalued right now?
Based on GuruFocus' analysis, Fischer Medical Ventures (BOM:524743) is currently considered Possible Value Trap. The stock's GF Value™ is ₹219.32, compared to a current price of ₹38.58 — trading 82.4% below its estimated fair value. The current Pretax Margin % is -2.32%. Fischer Medical Ventures' overall GF Score™ is 40/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Fischer Medical Ventures (BOM:524743), the current Pretax Margin % is -2.32% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fischer Medical Ventures (BOM:524743) Overvalued in 2026?
Based on GuruFocus' analysis, Fischer Medical Ventures stock appears to be undervalued.
The current stock price of ₹38.58 is trading 82.4% below its estimated GF Value™ of ₹219.32.
GuruFocus considers Fischer Medical Ventures to be Possible Value Trap.
Key valuation signals for BOM:524743:
Pretax Margin %: -2.32%
GF Value™: ₹219.32 vs. price of ₹38.58 (82.4% below fair value)
No single metric tells the full story. See the BOM:524743 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fischer Medical Ventures Ltd is engaged in developing and trading of Medical Equipment including cutting-edge Magnetic Resonance Imaging (MRI) systems in India.
40GF Score
Get the complete analysis for BOM:524743
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524743 has been successfully added to your 
